Monday, May 22, 2017

EMED Partners with Global Pharma Leaders in New FDA 510(k) Clearance

http://ift.tt/2qNub2q

EMED Technologies develops, manufactures and markets the SCIg60™ Infusion System. This unique sub-q infusion system is the only mechanical syringe pump system cleared by FDA for use with subcutaneous immunoglobulin Hizentra, Gammagard and Shire’s new Cuvitru. EMED products include Soft-Glide® needle sets, patented VersaRate® and Versarate Plus® adjustable and fixed flow rate control sets and flow rate calculators which can be accessed at www.versarate.com.EL DORADO HILLS, Calif., May 22, 2017 /PRNewswire/ — EMED Technologies Corporation is pleased to announce the SCIg60 Infusion System has been granted expanded indications as the only Immune Globulin Subcutaneous (Human) mechanical pump infusion system cleared by the U.S. FDA. The FDA…

May 22, 2017 at 10:50PM

http://ift.tt/2qcUsDs

from

http://ift.tt/2qcUsDs


at

No comments:

Post a Comment